Mario Raviglione, MD, is the World Health Organization’s Director of the Stop TB Department. He is a world leader in devising strategies to fight multi-drug resistant tuberculosis (MDR-TB). In an interview with John Donnelly on Friday, he responded to comments made by Ezekiel “Zeke” Emanuel, MD, PhD, Special Advisor for Health Policy at the Office of Management and Budget, in a blog post filed Thursday on Science Speaks. Here are excerpts from Raviglione’s interview.
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
The Ebola Virus is Winning – This comprehensive analysis by J. Stephen Morrison of the Center for Strategic & International Studies explains how with unprecedented advantages […]